| Literature DB >> 35102222 |
Heidi Cecilie Villmones1, Marius Svanevik2,3, Elling Ulvestad4,5, Tore Stenstad6, Inger Lill Anthonisen7, Randi Monsen Nygaard5, Ruben Dyrhovden5, Øyvind Kommedal4,5.
Abstract
Descriptions of the small intestinal microbiota are deficient and conflicting. We aimed to get a reliable description of the jejunal bacterial microbiota by investigating samples from two separate jejunal segments collected from the luminal mucosa during surgery. Sixty patients with morbid obesity selected for elective gastric bypass surgery were included in this survey. Samples collected by rubbing a swab against the mucosa of proximal and mid jejunal segments were characterized both quantitatively and qualitatively using a combination of microbial culture, a universal quantitative PCR and 16S deep sequencing. Within the inherent limitations of partial 16S sequencing, bacteria were assigned to the species level. By microbial culture, 53 patients (88.3%) had an estimated bacterial density of < 1600 cfu/ml in both segments whereof 31 (51.7%) were culture negative in both segments corresponding to a bacterial density below 160 cfu/ml. By quantitative PCR, 46 patients (76.7%) had less than 104 bacterial genomes/ml in both segments. The most abundant and frequently identified species by 16S deep sequencing were associated with the oral cavity, most often from the Streptococcus mitis group, the Streptococcus sanguinis group, Granulicatella adiacens/para-adiacens, the Schaalia odontolytica complex and Gemella haemolysans/taiwanensis. In general, few bacterial species were identified per sample and there was a low consistency both between the two investigated segments in each patient and between patients. The jejunal mucosa of fasting obese patients contains relatively few microorganisms and a core microbiota could not be established. The identified microbes are likely representatives of a transient microbiota and there is a high degree of overlap between the most frequently identified species in the jejunum and the recently described ileum core microbiota.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35102222 PMCID: PMC8803847 DOI: 10.1038/s41598-022-05723-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Patient characteristics.
| Population characteristics | Number of patients (n = 60) | Percent |
|---|---|---|
| Age years, median (range) | 45 (19–65) | |
| BMI kg/m2, median (range) | 41 (34–57) | |
| Gender, male | 18 | 30 |
| Gender, female | 42 | 70 |
| ASA score 1 | 0 | 0 |
| ASA score 2 | 3 | 5 |
| ASA score 3 | 56 | 93 |
| ASA score 4 | 1 | 2 |
| Current smoker | 0 | 0 |
| Systolic BP, mean (95%CI) | 136 (132–140) | |
| Diastolic BP, mean (95%CI) | 85 (83–87) | |
| 49 | 82 | |
| Diabetes, any type | 10 | 17 |
| Peroral antidiabetics | 7 | 12 |
| Insulin dependant | 1 | 2 |
| Hypertension | 21 | 35 |
| Dyslipidemia | 12 | 20 |
| Obstructive sleep apnea (OSA) | 17 | 28 |
| OSA with CPAP | 15 | 25 |
| Previous cholecystectomy | 10 | 17 |
| Proton pump inhibitor | 14 | 23 |
BMI Body Mass Index, ASA American Society of Anesthesiologists, BP blood pressure, CPAP continuous positive airway pressure.
Microbiological densities estimated in jejunum by aerobic and anaerobic culture.
| Growth | cfu/ml | Proximal jejunum ( | Mid jejunum ( | Patient level ( | |
|---|---|---|---|---|---|
| No growth | < 160 | 34 | 43 | 51.7% (31) | 88.3% |
| Single colony/broth only | 160– < 1600 | 21 | 13 | 36.7% (22) | |
| Sparse growth | 1600– < 8000 | 3 | 0 | 3.3% (2) | 11.6% |
| Moderate growth | 0.8–1.6 × 104 | 1 | 2 | 3.3% (2) | |
| Abundant growth | > 1.6 × 104 | 1 | 2 | 5% (3) | |
| In total | 60 | 60 | 100% | 100% |
*Counted by the most bacteria rich segment.
Figure 1Relative distribution of most abundant genera in (a) proximal part of jejunum and (b) jejunal mid-segment. All 60 patients included. Samples are sorted by increasing bacterial concentration. Samples with concentration below the level of quantification (Ct-value ≥ 34.17) are sorted by name on the left side (35 proximal samples 1j-60j and 38 mid-segment samples, 1i-60i).
Figure 2Comparison of most frequent species in upper and middle jejunum. (y axis number of patients). Based on all 60 patients.
Microbial densities estimated by quantitative 16S rRNA PCR.
| Genome copies/ml | Proximal jejunum ( | Mid jejunum ( | Patient level (n) (Both segments combined)* |
|---|---|---|---|
| 105– < 106 | 5% (3) | 5% (3) | 5% (3) |
| 104– < 105 | 16.7% (10) | 6.7% (4) | 18.3% (11) |
| 2.9 × 103– < 104 | 20% (12) | 25% (15) | 36.7% (22) |
| < 2.9 × 103 | 58.3% (35) | 63.3% (38) | 40% (24) |
*Counted by the most microbial genome-rich segment.
Figure 3(a) Previously reported ileum core microbiota (based on 27 patients) sorted by frequency (%) compared to observed frequency in jejunum (upper and middle segment combined for all 60 patients) and (b). Most frequently detected species in jejunum (upper and middle segment combined) sorted by frequency (%) compared to previously reported frequency in ileum. Based on all 60 patients.
Quantification by microbial culture.
| Growth | Colonies on plate | Cfu/ ml | Growth |
|---|---|---|---|
| No growth (lower limit of detection) | 0 | < 160 | Non-substantial < 1600 cfu/ml |
| Single colonies/ broth only | 1–9 | 160– < 1600 | |
| Sparsely growth | 10–49 | 1600– < 8000 | Substantial ≥ 1600 cfu/ml |
| Moderate growth | 50–100 | 0.8–1.6 × 104 | |
| Abundant growth (upper limit of detection) | > 100 | > 1.6 × 104 |